Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures +0.82%, Hang Seng Futures +0.72%, ASX SPI 200 +0.03%, S&P Futures +0.05%

Jan 08 ,2026

  • Synopsis:

    • Asia equities poised to open mostly higher Friday. Futures in Japan, Hong Kong and Australia traded firmer, while South Korea marginally lower. Almost all Japan ADRs advanced, while Golden Dragon China index rose a solid 1.09%. US contracts little changed after a mostly higher close in the cash session that saw notably positive breadth. Energy and defense continued to outperform. But tech leads were negative with Nasdaq lagging among the main benchmarks, SOX index down 1.83% and big tech mostly lower. US Treasuries were weaker with slight curve steepening. Dollar index was up 0.2%. Gold finished little changed. Silver ended down 3.2% (rebalancing pressure flagged). Bitcoin futures were down 0.2%. WTI crude settled up 3.2%.

    • Growing debate over whether recent signs of market softness represent a mere pause ahead of key risk events or the start of a more genuine sea change in sentiment in light of a new phase of uncertainty. Latter scenario plays into evidence of defensive rotation and small cap outperformance. US payrolls data remains the immediate focus, though market radar also dotted with several other potential catalysts. Latest Fed policy rhetoric dovish -- Bessent reiterated rates should be lower, Miran advocated 150 bp in rate cuts this year. Supreme Court ruling on IEEPA tariffs coming to fore with a decision to come as early as Friday. Bloomberg reported the list of companies participating in the litigation has surged beyond 1,000. On the Fed chair nomination, Treasury Secretary Bessent suggested Trump may decide around the Davos forum scheduled for Jan 19-23. Major bank results next week to mark the first major checkpoint in Q4 earnings.

    • Some reverberations from a report last night indicating China plans to approve some Nvidia (NVDA) H200 imports as soon as Q1. Follows recent remarks by Nvidia that China demand is strong, though amid ongoing lack of clarity over when/how Beijing would allow purchases amid policy guidance encouraging tech firms to procure domestic chips. With rare earths back in the spotlight after China banned dual-use exports to Japan, White House trade adviser Navarro predicted US innovation would "quickly wipe away" China's dominance in the field though there were no specifics. China Commerce Ministry reassured ban will only affect Japanese military firms, yet pressure tactics continue elsewhere; customs clearance for Japanese alcoholic beverages and food products reportedly being delayed, Commerce Ministry on Wednesday launched an anti-dumping probe into special gases used in the production of semiconductors and LCDs.

  • Pre-open Company News:

    • 6488.TT -- GlobalWafers reports December revenue NT$5.51B, +0.3% y/y

    • 2196.HK -- Shanghai Fosun Pharmaceutical (Group)'s drug registration application for Foritinib Succinate Capsules accepted by NMPA

    • 1777.HK -- Fantasia Holdings Group to seek Cayman Islands court order to convene scheme meeting

    • 532522.IN -- Ministry of Petroleum & Natural Gas nominates secretary Neeraj Mittal to Petronet LNG board succeeding Pankaj Jain

    • L'Oreal, Kering among companies maintaining Triple A ranking in CDP's 2025 climate disclosure list (8-Jan)

    • 1238.HK -- Powerlong Real Estate Holdings reports December contracted sales CNY607M; StreetAccount notes the year-ago figure was CNY1.05B

    • 6669.TT -- Wiwynn reports Q4 EPS NT$74.21 vs FactSet NT$68.29 [14 est, NT$55.50-83.22]

    • 3037.TT -- Unimicron Technology reports December revenue NT$11.82B, +26.9% y/y

    • 4503.JP -- Astellas discloses new ad hoc analyses of VYLOY (zolbetuximab) plus chemotherapy when common adverse events are effectively managed

    • 300498.CH -- Wen's Foodstuff Group guides FY net income attributable CNY5.00-5.50B vs FactSet CNY7.04B [15 est, CNY5.00-9.65B]

    • Hong Kong stock connect daily turnover

    • 11.HK -- HSBC Holdings announces Hang Seng Bank shareholders approve privatisation proposal

    • 2186.HK -- Luye Pharma Group's NDA for new indication of Ruoxinlin accepted by NMPA

  • On Deck:

    • China:

      • Economic:

        • 08:00 CST: M2 NSA Y/Y; consensus

        • 08:00 CST: New Yuan Loans; consensus

        • 08:00 CST: Loan Growth Y/Y; consensus

        • 09:30 CST: PPI NSA Y/Y; consensus

        • 09:30 CST: CPI NSA Y/Y; consensus (0.2%)

    • Japan:

      • Economic:

        • 08:30 JST: Real Household Consumption Expenditure Y/Y; consensus

        • 08:30 JST: Real Household Income Y/Y; consensus

        • 08:50 JST: FX Reserves M/M; consensus

        • 14:00 JST: Leading Index (Preliminary); consensus

      • Earnings:

        • Jins Holdings (3046.JP), Rorze Corp (6323.JP), YASKAWA Electric (6506.JP), Kohnan Shoji (7516.JP), Nomura Co. (9716.JP), Belc Co. (9974.JP)

    • New Zealand:

      • Earnings:

        • Summerset Group Holdings (SUM.NZ)

    • Taiwan:

      • Economic:

        • 16:00 TST: Export NSA Y/Y; consensus +53.7%

  • Market Data:

    • Gold (Feb 26): +$26.10 or +0.59% to $4486.80

    • WTI Crude (Feb 26): +$0.60 or +1.04% to $58.36

    • $-¥: +0.13 or +0.09% to 156.9020

    • $-KRW: +0.76 or +0.05% to 1450.4720

    • A$-$: (0.00) or (0.34%) to 0.6699

    • $-INR: +0.04 or +0.04% to 89.9465

    • $-CNY: (0.01) or (0.21%) to 6.9828

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE